Stock in focus: BIEL

Todays alert AUCI and SWME was up by 1150% and 350% respectively. Congratulations for SOMX and IMGG gain, its more then 285% and 135% up respectively, since the time it was alerted. Last time stock in focus AEN went up by 400%, APPY is up by 70%, This time stock in focus is BIEL which i think is undervalued stock, presently trading at $0.028. I think it has potential to be big winner in near future.

RSI indicator is at 33.0 and MACD indicator shows buy signal for BIEL.

On sept 22nd 2009, they announced filing with the U.S. Government's Food and Drug Administration for 510(K) premarketing clearance for its ActiPatch Therapy products. Recently they submitted reclassification application and they entered Chinese market too.

Actipatch has the following approvals:

US FDA clearance for the treatment of edema following Blepharoplasty

Canadian market approval for relief of pain in muscosketal complaints in both medical and over-the-counter markets

CE Mark (European Common Market) Certification for the medical and retail over-the-counter markets in Korea, Singapore, Australia and Saudi Arabia

Over-the-counter markets in Korea, Singapore, Australia and Saudi Arabia

The dermal patch delivery system creates a multitude of new product opportunities for chronic and acute inflammatory conditions. The market potential is estimated at $10 billion or 400 million incidents worldwide. The distinctive value proposition of ActiPatch is the delivery of drug-free therapy that reduces pain and inflammation and accelerates healing by 30% to 50% when compared with the present standard methods of patient care. The current major applications are:

• Medical Surgeries
• Chronic Wounds
• Oral Surgeries
• Sprains and Strains
• Lower Back Pain
• Chronic Repetitive Stress Injuries, Heel Pain, Carpal Tunnel, Bursitis, etc.


Below is a list of the Company’s accomplishments to date.

• United States Food and Drug Administration market clearance

• Canadian market approval for relief of pain in muscosketal complaints in both medical and over-the-counter markets

• CE Mark (European Common Market) Certification for the medical and retail over-the-counter markets

• ISO Certification

Disclosure: Long